[go: up one dir, main page]

HK1049107A1 - 用於治疗肺疾病的方法和组合物 - Google Patents

用於治疗肺疾病的方法和组合物 Download PDF

Info

Publication number
HK1049107A1
HK1049107A1 HK02109234.5A HK02109234A HK1049107A1 HK 1049107 A1 HK1049107 A1 HK 1049107A1 HK 02109234 A HK02109234 A HK 02109234A HK 1049107 A1 HK1049107 A1 HK 1049107A1
Authority
HK
Hong Kong
Prior art keywords
compositions
pulmonary diseases
treating pulmonary
treating
diseases
Prior art date
Application number
HK02109234.5A
Other languages
English (en)
Chinese (zh)
Inventor
N. Goodfellow Peter
Nieman Richard
J. Torphy Theodore
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of HK1049107A1 publication Critical patent/HK1049107A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02109234.5A 1999-11-02 2000-11-01 用於治疗肺疾病的方法和组合物 HK1049107A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
US60/163,158 1999-11-02
PCT/US2000/030113 WO2001032127A2 (fr) 1999-11-02 2000-11-01 Procede et compositions pour traiter des maladies respiratoires

Publications (1)

Publication Number Publication Date
HK1049107A1 true HK1049107A1 (zh) 2003-05-02

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02109234.5A HK1049107A1 (zh) 1999-11-02 2000-11-01 用於治疗肺疾病的方法和组合物

Country Status (29)

Country Link
EP (1) EP1225866A4 (fr)
JP (1) JP2003513028A (fr)
KR (1) KR20020057988A (fr)
CN (1) CN1387404A (fr)
AP (1) AP2002002496A0 (fr)
AR (1) AR029189A1 (fr)
AU (1) AU1357501A (fr)
BG (1) BG106748A (fr)
BR (1) BR0015270A (fr)
CA (1) CA2388333A1 (fr)
CO (1) CO5261512A1 (fr)
CZ (1) CZ20021512A3 (fr)
DZ (1) DZ3225A1 (fr)
EA (1) EA200200518A1 (fr)
EC (1) ECSP003747A (fr)
HK (1) HK1049107A1 (fr)
HU (1) HUP0203152A3 (fr)
IL (1) IL149367A0 (fr)
MA (1) MA26841A1 (fr)
MX (1) MXPA02004350A (fr)
NO (1) NO20022057L (fr)
OA (1) OA12076A (fr)
PE (1) PE20011005A1 (fr)
PL (1) PL355261A1 (fr)
SK (1) SK7592002A3 (fr)
TR (1) TR200201211T2 (fr)
TW (1) TWI242431B (fr)
WO (1) WO2001032127A2 (fr)
ZA (1) ZA200203435B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2282469T3 (es) 2001-09-19 2007-10-16 Nycomed Gmbh Combinacion de un nsaid y un inhibidor de pde-4.
CZ2004516A3 (cs) * 2001-10-31 2004-08-18 Merckápatentágmbh Inhibitor fosfodiesterázy typu @Ź jeho kombinace s jinými drogami a jeho použití
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
EP1616569A1 (fr) * 2003-03-31 2006-01-18 Kyowa Hakko Kogyo Co., Ltd. Composition therapeutique
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
JPWO2006041121A1 (ja) * 2004-10-13 2008-05-15 協和醗酵工業株式会社 慢性皮膚疾患の治療および／または予防剤
AU2006305620A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
JP6017961B2 (ja) 2010-01-05 2016-11-02 マイクロドース セラピューテクス，インコーポレイテッド 吸入デバイスおよび方法
WO2015063669A1 (fr) 2013-10-30 2015-05-07 Wockhardt Limited Compositions pharmaceutiques comprenant une combinaison de roflumilast et d'acébrophylline ou de leurs sels pharmaceutiquement acceptables

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69433997T2 (de) * 1993-06-18 2005-01-27 Smithkline Beecham Corp. Verfahren zur Identifizierung eines PDE IV Hemmers
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
WO2001032127A2 (fr) 2001-05-10
EP1225866A4 (fr) 2004-04-21
HUP0203152A2 (hu) 2003-01-28
CA2388333A1 (fr) 2001-05-10
ECSP003747A (es) 2002-05-23
CN1387404A (zh) 2002-12-25
CO5261512A1 (es) 2003-03-31
WO2001032127A3 (fr) 2001-12-06
NO20022057L (no) 2002-06-27
TWI242431B (en) 2005-11-01
AU1357501A (en) 2001-05-14
IL149367A0 (en) 2002-11-10
NO20022057D0 (no) 2002-04-30
PE20011005A1 (es) 2001-09-28
JP2003513028A (ja) 2003-04-08
AP2002002496A0 (en) 2002-06-30
ZA200203435B (en) 2003-06-25
OA12076A (en) 2006-05-04
BR0015270A (pt) 2002-06-18
PL355261A1 (en) 2004-04-05
CZ20021512A3 (cs) 2003-04-16
EP1225866A2 (fr) 2002-07-31
MA26841A1 (fr) 2004-12-20
HUP0203152A3 (en) 2004-06-28
BG106748A (en) 2003-02-28
SK7592002A3 (en) 2002-11-06
TR200201211T2 (tr) 2002-08-21
AR029189A1 (es) 2003-06-18
MXPA02004350A (es) 2002-11-07
EA200200518A1 (ru) 2002-10-31
KR20020057988A (ko) 2002-07-12
DZ3225A1 (fr) 2001-05-10

Similar Documents

Publication Publication Date Title
WO2003011274A3 (fr) Methode therapeutique
MY126544A (en) Therapies for treating pulmonary diseases
EP1602370A3 (fr) Mélange synergétique comprenant un inhibiteur de la rénine pour le traitement des maladies cardiovasculaires
WO2003000241A3 (fr) Nouvelles compositions de medicament a base d'anticholinergiques, de corticosteroides et d'agents beta-mimetiques
WO2004021989A3 (fr) Imidazolopyridines, procedes de fabrication et methodes d'utilisation
AU2001271973A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
WO2001083554A3 (fr) Composes anti-inflammatoires et leurs utilisations
WO2003051380A3 (fr) Composition destinee au traitement de troubles neurocerebrovasculaires
WO2004022523A3 (fr) Derives de promedicaments a base de 1, 3-diamino-2-hydroxypropane
WO2004078712A3 (fr) Derives d'isoquinoline et leurs methodes d'utilisation
WO2005009349A3 (fr) Composition et methode pour traiter des troubles neurologiques
BR0009446A (pt) Composto, processo para preparar o mesmo, composição uso de um composto, e, métodos para o tratamento ou a prevenção de uma doença em um mamìfero, para o tratamento ou a prevenção de asma em um mamìfero e para o tratamento ou a prevenção de doença pulmonar obstrutiva crÈnica em um mamìfero
HK1049107A1 (zh) 用於治疗肺疾病的方法和组合物
WO2001051044A3 (fr) Substances utilisees dans le traitement du psoriasis
IL165378A0 (en) Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
AUPS017702A0 (en) Methods and compositions for the treatment of asthma and related disorders
SE9900833D0 (sv) Novel combination
WO1999012933A3 (fr) Derives de pyrrolopyrrolone en tant qu'inhibiteurs de neutrophile elastase
WO2002017894A3 (fr) Utilisation d'une combinaison de salmeterol et de propionate de fluticasone
WO2003039464A3 (fr) Aerosol antimuscarinique
WO2005011608A3 (fr) Combinaison de deshydroepiandrosterone ou deshydroepiandrosterone-sulfate avec un derive de methylxanthine pour le traitement de l'asthme ou de maladie pulmonaire obstructive chronique
SE9900834D0 (sv) Novel combination
WO2005011604A3 (fr) Combinaison constituee de deshydroepiandrosterone ou de deshydroepiandrosterone-sulfate et d'un antihistaminique destinee au traitement de l'asthme ou de la bronchopneumopathie chronique obstructive
HUP0102388A3 (en) Use of diazepinoindole derivatives for the preparation of pharmaceutical composition treating chronic obstructive pulmonary disease
WO2000021512A3 (fr) Composition et procede pour le traitement d'allergies